Center for Primary Health Care Research, Lund University, Malmö, Sweden
GeneWerk GmbH, Heidelberg, Germany
Search for other papers by Hauke Thomsen in
Google Scholar
PubMed
Search for other papers by Xinjun Li in
Google Scholar
PubMed
Departments of Family Medicine and Community Health, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Shimane, Japan
Search for other papers by Kristina Sundquist in
Google Scholar
PubMed
Departments of Family Medicine and Community Health, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Shimane, Japan
Search for other papers by Jan Sundquist in
Google Scholar
PubMed
Center for Primary Health Care Research, Lund University, Malmö, Sweden
Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany
Division of Pediatric Neurooncology, German Cancer Research Centre (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
Search for other papers by Asta Försti in
Google Scholar
PubMed
Center for Primary Health Care Research, Lund University, Malmö, Sweden
Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic
Search for other papers by Kari Hemminki in
Google Scholar
PubMed
-morbidity of at least two of the following three AIDs: AD, type 1 diabetes or autoimmune thyroid disease, but it may also include other AIDs ( 4 ). AD patients may present with multiple AIDs, irrespective of APS-2; among Norwegian and Swedish patients only less
Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand
Search for other papers by M S Elston in
Google Scholar
PubMed
Search for other papers by V B Crawford in
Google Scholar
PubMed
Search for other papers by M Swarbrick in
Google Scholar
PubMed
Search for other papers by M S Dray in
Google Scholar
PubMed
Search for other papers by M Head in
Google Scholar
PubMed
Search for other papers by J V Conaglen in
Google Scholar
PubMed
, carcinoid tumour and teratoma) ( 4 , 5 , 6 ) and genitourinary sources including the prostate ( 7 ) as well as cloacogenic carcinoma of the anal canal ( 8 ). Prostate cancer causing CS due to ectopic ACTH or CRH production is rare with <30 published cases
Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
hyperthyroidism, such as Hashimoto’s disease with hyperthyroidism, neonatal hyperthyroidism, or hyperthyroidism due to rare conditions like McCune Albright syndrome or non-immune hyperthyroidism. Our study provides information regarding clinical features and long
Search for other papers by Elizaveta Mamedova in
Google Scholar
PubMed
Search for other papers by Natalya Mokrysheva in
Google Scholar
PubMed
Search for other papers by Evgeny Vasilyev in
Google Scholar
PubMed
Search for other papers by Vasily Petrov in
Google Scholar
PubMed
Search for other papers by Ekaterina Pigarova in
Google Scholar
PubMed
Search for other papers by Sergey Kuznetsov in
Google Scholar
PubMed
Search for other papers by Nikolay Kuznetsov in
Google Scholar
PubMed
Search for other papers by Liudmila Rozhinskaya in
Google Scholar
PubMed
Institute of Clinical Endocrinology, Endocrinology Research Center, Moscow, Russian Federation
Search for other papers by Galina Melnichenko in
Google Scholar
PubMed
Search for other papers by Ivan Dedov in
Google Scholar
PubMed
Search for other papers by Anatoly Tiulpakov in
Google Scholar
PubMed
typically the first manifestation of the disease, the onset is usually between ages 20 and 25 years, and it is caused by multiple parathyroid hyperplasia or adenomas ( 6 ). PHPT in HPT-JT has been observed in up to 95% of affected individuals, with the
Search for other papers by Natalie Rogowski-Lehmann in
Google Scholar
PubMed
Search for other papers by Aikaterini Geroula in
Google Scholar
PubMed
Search for other papers by Aleksander Prejbisz in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Felix Megerle in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Stephanie M J Fliedner in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Search for other papers by Anthony Stell in
Google Scholar
PubMed
Search for other papers by Andrzej Januszewicz in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
diagnosed by imaging and concomitant syndromic presentation, positive family history or metastatic disease. # Clinical context Reason for inclusion as putatively incidental 1 Family history or syndromic presentation First
Search for other papers by Rimesh Pal in
Google Scholar
PubMed
Search for other papers by Sanjay Kumar Bhadada in
Google Scholar
PubMed
Search for other papers by Awesh Singhare in
Google Scholar
PubMed
Search for other papers by Anil Bhansali in
Google Scholar
PubMed
Search for other papers by Sadishkumar Kamalanathan in
Google Scholar
PubMed
Search for other papers by Manoj Chadha in
Google Scholar
PubMed
Search for other papers by Phulrenu Chauhan in
Google Scholar
PubMed
Search for other papers by Ashwani Sood in
Google Scholar
PubMed
Search for other papers by Vandana Dhiman in
Google Scholar
PubMed
Search for other papers by Dinesh Chandra Sharma in
Google Scholar
PubMed
Search for other papers by Uma Nahar Saikia in
Google Scholar
PubMed
Search for other papers by Debajyoti Chatterjee in
Google Scholar
PubMed
Search for other papers by Vikas Agashe in
Google Scholar
PubMed
Introduction Tumor-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome characterized by persistent hypophosphatemia. The basic pathophysiology of underlying hypophosphatemia is increased renal
Search for other papers by Dimitra Argyro Vassiliadi in
Google Scholar
PubMed
Search for other papers by Ioannis Ilias in
Google Scholar
PubMed
Search for other papers by Maria Pratikaki in
Google Scholar
PubMed
Search for other papers by Edison Jahaj in
Google Scholar
PubMed
Search for other papers by Alice G Vassiliou in
Google Scholar
PubMed
Search for other papers by Maria Detsika in
Google Scholar
PubMed
Search for other papers by Kleio Ampelakiotou in
Google Scholar
PubMed
Search for other papers by Marina Koulenti in
Google Scholar
PubMed
Search for other papers by Konstantinos N Manolopoulos in
Google Scholar
PubMed
Search for other papers by Stamatis Tsipilis in
Google Scholar
PubMed
Search for other papers by Evdokia Gavrielatou in
Google Scholar
PubMed
Search for other papers by Aristidis Diamantopoulos in
Google Scholar
PubMed
Search for other papers by Alexandros Zacharis in
Google Scholar
PubMed
Search for other papers by Nicolaos Athanasiou in
Google Scholar
PubMed
Search for other papers by Stylianos Orfanos in
Google Scholar
PubMed
Search for other papers by Anastasia Kotanidou in
Google Scholar
PubMed
Search for other papers by Stylianos Tsagarakis in
Google Scholar
PubMed
Search for other papers by Ioanna Dimopoulou in
Google Scholar
PubMed
Introduction With the emergence of the COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it was soon realized that the disease affects not only the respiratory system but also multiple organs and
Search for other papers by Felix Reschke in
Google Scholar
PubMed
Search for other papers by Torben Biester in
Google Scholar
PubMed
Search for other papers by Thekla von dem Berge in
Google Scholar
PubMed
Search for other papers by Dagmar Jamiolkowski in
Google Scholar
PubMed
Search for other papers by Laura Hasse in
Google Scholar
PubMed
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Search for other papers by Katharina Klee in
Google Scholar
PubMed
Search for other papers by Olga Kordonouri in
Google Scholar
PubMed
Search for other papers by Hagen Ott in
Google Scholar
PubMed
Search for other papers by Thomas Danne in
Google Scholar
PubMed
patients, metabolic disorders and sensorineural hearing loss. In addition, several organ systems, such as the heart or kidney, can be affected. Alström syndrome is a very rare disease. About 270 cases have been described in the literature so far (2017
Search for other papers by Mette H Viuff in
Google Scholar
PubMed
Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Turner syndrome (TS) is a condition with a missing X chromosome (45,X) or parts thereof or with a mosaic setup (45,X/46,XX or other variants). It is a rare disease. New international guidelines describe an appropriate setup for optimal clinical
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), ISCIII, Spain
Department of Endocrinology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
Search for other papers by Susan M Webb in
Google Scholar
PubMed
Search for other papers by Jette Kristensen in
Google Scholar
PubMed
Search for other papers by Anna Nordenström in
Google Scholar
PubMed
Search for other papers by Diana Vitali in
Google Scholar
PubMed
Search for other papers by Vincent Amodru in
Google Scholar
PubMed
Search for other papers by Lenja Katharina Wiehe in
Google Scholar
PubMed
Search for other papers by Matt Bolz-Johnson in
Google Scholar
PubMed
their implementation in 2017 is to tackle the current hurdles of complex or rare diseases and to connect collective experience and expertise across Europe, facilitating the knowledge to travel instead of the patient. Collecting data on PJ from different